Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis

Mount Sinai Medical Center, New York

Fox Chase Cancer Center, Philadelphia

Amyloidosis Research & Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia

Barbara Ann Karmanos Cancer Institute, Detroit

Mayo Clinic, Rochester

CHU Limoges, Department of Hematology and Cell Therapy, Reference Center for AL amyloidosis, Limoges

Tufts Medical Center, Boston

Boston Medical Center, Boston

University Health Network, Toronto

Universitatsklinikum Heidelberg Innere Medizin V; Hamatologie, Onkologie und Rheumatologie, Heidelberg